Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Foon

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Annals of Hematology|September 22, 2010
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapyMichael Boyiadzis, Robert L Redner, Anastasios Raptis, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2009
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptorsMiroslaw J Szczepanski, Marta Szajnik, Ann Welsh, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patientsMary T Litzinger, Kenneth A Foon, Helen Sabzevari, et al.
Cancer Biology & Therapy|December 7, 2007
Generation of Her-2/neu vaccine utilizing idiotypic network cascadeSmarajit Pal, Asim Saha, Kartik Mohanty, et al.
Breast Cancer Research and Treatment|September 28, 2006
Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neuKartik Mohanty, Asim Saha, Smarajit Pal, et al.
Leukemia & Lymphoma|December 27, 2013
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium StudyMark H Kirschbaum, Kenneth A Foon, Paul Frankel, et al.
Cancer Research|July 17, 2004
Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic miceAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
International Immunology|May 10, 2011
The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cellsLela Kardava, Qi Yang, Anthony St Leger, et al.
Blood|August 6, 2005
Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory moleculesClaudia Palena, Kenneth A Foon, Dennis Panicali, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigenRathindra Nath Baral, Asim Saha, Sunil K Chatterjee, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Annals of Hematology|September 22, 2010
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapyMichael Boyiadzis, Robert L Redner, Anastasios Raptis, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2009
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptorsMiroslaw J Szczepanski, Marta Szajnik, Ann Welsh, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2008
Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patientsMary T Litzinger, Kenneth A Foon, Helen Sabzevari, et al.
Cancer Biology & Therapy|December 7, 2007
Generation of Her-2/neu vaccine utilizing idiotypic network cascadeSmarajit Pal, Asim Saha, Kartik Mohanty, et al.
Breast Cancer Research and Treatment|September 28, 2006
Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neuKartik Mohanty, Asim Saha, Smarajit Pal, et al.
Leukemia & Lymphoma|December 27, 2013
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium StudyMark H Kirschbaum, Kenneth A Foon, Paul Frankel, et al.
Cancer Research|July 17, 2004
Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic miceAsim Saha, Sunil K Chatterjee, Kenneth A Foon, et al.
International Immunology|May 10, 2011
The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cellsLela Kardava, Qi Yang, Anthony St Leger, et al.
Blood|August 6, 2005
Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory moleculesClaudia Palena, Kenneth A Foon, Dennis Panicali, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigenRathindra Nath Baral, Asim Saha, Sunil K Chatterjee, et al.
Pageof 5